Literature DB >> 2840818

Myopathy in complex glycerol kinase deficiency patients is due to 3' deletions of the dystrophin gene.

B T Darras1, U Francke.   

Abstract

DNA samples from nine previously reported patients with X-linked recessive glycerol kinase deficiency, associated in seven of them with adrenal hypoplasia and in five with developmental delay and myopathy, have been studied for deletions of the Duchenne/Becker muscular dystrophy gene by probing with the entire cDNA for the dystrophin protein. All five patients with myopathy, including two in whom no deletions had been detected before, were found to have variable-sized deletions extending through the 3' end of this gene. The 5' deletion breakpoints are intragenic in four cases and have been mapped precisely on the exon-containing HindIII fragment map. A correlation was found between severity and progression of the muscular dystrophy phenotype and the sizes of the gene deletions. In cases in which there was glycerol kinase deficiency/adrenal hypoplasia microdeletion syndrome without myopathy, no deletions were found with the dystrophin cDNA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840818      PMCID: PMC1715358     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  10 in total

1.  Infantile glycerol kinase deficiency--a condition requiring prompt identification. Clinical, biochemical, and morphological findings in two cases.

Authors:  A Kohlschütter; H P Willig; D Schlamp; K Kruse; E R McCabe; H J Schäfer; G Beckenkamp; R Rohkamm
Journal:  Eur J Pediatr       Date:  1987-11       Impact factor: 3.183

2.  Inherited Xp21 deletion in a boy with complex glycerol kinase deficiency syndrome.

Authors:  F Saito; J Goto; H Kakinuma; F Nakamura; S Murayama; I Nakano; A Tonomura
Journal:  Clin Genet       Date:  1986-01       Impact factor: 4.438

3.  Prenatal diagnosis and detection of carriers with DNA probes in Duchenne's muscular dystrophy.

Authors:  B T Darras; J F Harper; U Francke
Journal:  N Engl J Med       Date:  1987-04-16       Impact factor: 91.245

4.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

5.  Phenotypic features of patients with congenital adrenal hypoplasia and glycerol kinase deficiency.

Authors:  J E Wise; R Matalon; A M Morgan; E R McCabe
Journal:  Am J Dis Child       Date:  1987-07

6.  Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals.

Authors:  M Koenig; E P Hoffman; C J Bertelson; A P Monaco; C Feener; L M Kunkel
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

7.  Congenital adrenal hypoplasia, myopathy, and glycerol kinase deficiency: molecular genetic evidence for deletions.

Authors:  U Francke; J F Harper; B T Darras; J M Cowan; E R McCabe; A Kohlschütter; W K Seltzer; F Saito; J Goto; J P Harpey
Journal:  Am J Hum Genet       Date:  1987-03       Impact factor: 11.025

8.  Glycerol kinase deficiency with neuromuscular, skeletal, and adrenal abnormalities.

Authors:  M A Guggenheim; E R McCabe; M Roig; S I Goodman; G M Lum; W W Bullen; S P Ringel
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

9.  Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA.

Authors:  B T Darras; M Koenig; L M Kunkel; U Francke
Journal:  Am J Med Genet       Date:  1988-03

10.  Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker.

Authors:  G J van Ommen; C Bertelson; H B Ginjaar; J T den Dunnen; E Bakker; J Chelly; M Matton; A J van Essen; J Bartley; L M Kunkel
Journal:  Genomics       Date:  1987-12       Impact factor: 5.736

  10 in total
  9 in total

1.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?

Authors:  D Récan; P Chafey; F Leturcq; J P Hugnot; N Vincent; F Tomé; H Collin; D Simon; P Czernichow; L V Nicholson
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

3.  Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA.

Authors:  B T Darras; U Francke
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

4.  Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications.

Authors:  J T Den Dunnen; P M Grootscholten; E Bakker; L A Blonden; H B Ginjaar; M C Wapenaar; H M van Paassen; C van Broeckhoven; P L Pearson; G J van Ommen
Journal:  Am J Hum Genet       Date:  1989-12       Impact factor: 11.025

5.  Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115.

Authors:  M R Passos-Bueno; D Rapaport; D Love; T Flint; E R Bortolini; M Zatz; K E Davies
Journal:  J Med Genet       Date:  1990-03       Impact factor: 6.318

6.  Characterization of patients with glycerol kinase deficiency utilizing cDNA probes for the Duchenne muscular dystrophy locus.

Authors:  J A Towbin; D R Wu; J Chamberlain; P D Larsen; W K Seltzer; E R McCabe
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

7.  A symptomatic female patient with Duchenne muscular dystrophy diagnosed by dystrophin-staining: a case report.

Authors:  K Shigihara-Yasuda; H Tonoki; Y Goto; K Arahata; N Ishikawa; N Kajii; K Fujieda
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

8.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.

Authors:  M Koenig; A H Beggs; M Moyer; S Scherpf; K Heindrich; T Bettecken; G Meng; C R Müller; M Lindlöf; H Kaariainen; A de la Chapellet; A Kiuru; M L Savontaus; H Gilgenkrantz; D Récan; J Chelly; J C Kaplan; A E Covone; N Archidiacono; G Romeo; S Liechti-Gailati; V Schneider; S Braga; H Moser; B T Darras; P Murphy; U Francke; J D Chen; G Morgan; M Denton; C R Greenberg; K Wrogemann; L A Blonden; M B van Paassen; G J van Ommen; L M Kunkel
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

9.  Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

Authors:  A H Beggs; E P Hoffman; J R Snyder; K Arahata; L Specht; F Shapiro; C Angelini; H Sugita; L M Kunkel
Journal:  Am J Hum Genet       Date:  1991-07       Impact factor: 11.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.